Is this your brand? Sign in to claim ownership.

RevisiOs B.V.

Last updated May 31, 2026

What RevisiOs B.V. makes

RevisiOs B.V. manufactures composite bone matrix implants designed to support bone regeneration and integration in surgical procedures. These products are intended for use in orthopaedic applications where structural support or volume replacement is required.

The company’s portfolio is classified under FDA’s Class II regulatory category and is listed in the FDA’s Unique Device Identifier (UDI) database. The manufacturer is based in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Information

Country: US
Address: —
Website: kurosbio.com
LinkedIn: —
Facebook: —
Email: [email protected]
Phone: +31307400500
PRRC Contact: —
EUDAMED SRN: —
FDA FEI Number: —
DUNS Number: 489274404

Catalogue (4)

Device	Model / Reference	Registries	Class	Status
OsOpia	702-023-US	FDA UDI	Class II	Active
OsOpia	702-024-US	FDA UDI	Class II	Active
OsOpia	702-021-US	FDA UDI	Class II	Active
OsOpia	702-022-US	FDA UDI	Class II	Active

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.